Search results for: '94 70'

Between 2012 and 2014, over 70 global companies that were valued at more than $1 billion were start-ups with unique and transformative new business models. During the same period, most business model innovators have managed to produce consistently profitable returns with a high average revenue gain. The keys to these success stories have been conne...

02 Jul 2018  |  Asia Pacific  |  Market Research

Growth Opportunities in the Asia-Pacific Demand Response Market, Forecast to 2025

Actual Accumulated Demand Response Resources to Cross 30GW by 2025

Infographics

×

Key Issues Addressed

The Asia-Pacific demand response market is in the growing stage with countries such as South Korea, Japan, and New Zealand in the forefront. The liberalization of electricity markets and increasing distributed energy resources have a major role in driving the growth of demand response. However, lack of standardized procedures and absence of incenti...

The care coordination workflow aims to optimize the entire value chain of patient care. The objective of this research service is to present a comprehensive analysis of the US care coordination software market, with respect to market potential and key market dynamics at play in the next 5 years. The regional scope of the analysis is the United Stat...

27 Nov 2017  |  North America  |  Market Research

Growth Opportunities in the Global Digital Pathology Market, Forecast to 2021

New Business Models and More FDA Approvals of WSI Scanners for Primary Diagnostics are Set to Boost Growth of Digital Pathology

Infographics

×

Key Issues Addressed

Shortage of pathologists and the rise in new cancer cases are the key drivers for the adoption of digital pathology solutions globally. Digital pathology enhances the productivity of pathologists by 10% to 15%, thereby improving the overall efficiency of healthcare providers. Digital pathology solutions find the best fit in oncology care. Accordin...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...

Sustainability targets in businesses are increasing to mitigate the risk of stringent regulations, taxation, and, more importantly, to meet customer demand for more environmentally friendly products. To achieve these goals, businesses adopt decarbonization strategies and invest in low-carbon technologies and services at different stages of the supp...